Elite Pharmaceuticals, Inc. (ELTP)
0.2468
0.00 (0.00%)
USD |
OTCM |
Sep 24, 16:00
Elite Pharmaceuticals Gross Profit (Annual) : 73.48M for March 31, 2026
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| March 31, 2026 | 73.48M |
| March 31, 2025 | 38.40M |
| March 31, 2024 | 24.98M |
| March 31, 2023 | 15.33M |
| March 31, 2022 | 13.60M |
| March 31, 2021 | 10.55M |
| March 31, 2020 | 6.659M |
| March 31, 2019 | 1.661M |
| March 31, 2018 | 3.147M |
| March 31, 2017 | 3.387M |
| March 31, 2016 | 7.348M |
| March 31, 2015 | 1.385M |
| March 31, 2014 | 0.8644M |
| March 31, 2013 | 0.9715M |
| March 31, 2012 | 1.204M |
| Date | Value |
|---|---|
| March 31, 2011 | 1.418M |
| March 31, 2010 | 0.8245M |
| March 31, 2009 | 0.3094M |
| March 31, 2008 | -0.1363M |
| March 31, 2007 | -0.1274M |
| March 31, 2006 | 0.064M |
| March 31, 2005 | -0.055M |
| March 31, 2004 | -0.0746M |
| March 31, 2003 | -1.694M |
| March 31, 2002 | -0.6785M |
| March 31, 2001 | -1.574M |
| March 31, 2000 | -2.065M |
| March 31, 1999 | -1.176M |
| March 31, 1998 | 0.00 |
| March 31, 1980 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Nektar Therapeutics | 54.21M |
| Daré Bioscience, Inc. | -1.417M |
| Eton Pharmaceuticals, Inc. | 42.74M |
| ANI Pharmaceuticals, Inc. | 450.64M |
| Corcept Therapeutics, Inc. | 748.43M |